FDA Approves Nausea Prevention Drug
- By admin aapc
- In Industry News
- September 2, 2008
- No Comments
The FDA has approved a new oral formulation of ALOXI(R) (palonosetron hydrochloride) made by Eisai Corporation of North America and its partner Helsinn Healthcare SA for the prevention of chemotherapy-induced nausea and vomiting (CINV) (Medical News Today, Aug. 24).
Latest posts by admin aapc (see all)
- Message From Your Region 7 Representatives | October 2018 - October 24, 2018
- Message From Your Region 6 Representatives | October 2018 - October 24, 2018
- Message From Your Region 5 Representatives | October 2018 - October 24, 2018
Leave a Reply